Home » Health » FDA Tightens Vaccine Approval Rules Amid Child Death Concerns

FDA Tightens Vaccine Approval Rules Amid Child Death Concerns

by Dr. Michael Lee – Health Editor

USA Examines‍ Child Deaths ​- FDA Wants to Tighten Vaccine Approval Regulations

The U.S. ⁢Food and Drug ⁣Administration (FDA) is moving to considerably tighten approval regulations for vaccines following new internal assessments suggesting a link between COVID-19 vaccinations and deaths in children. This development was reported by the‌ Washington Post.

Vinay Prasad, the ⁢FDA’s top​ vaccine ⁣regulator, stated his⁣ team​ has concluded “that corona vaccinations are linked to deaths in children” and that a new regulatory approach is ​necessary. The ⁤FDA has‍ not yet released specific details regarding the cases under examination.

These assessments are based on internal agency analyses and reports submitted to the Vaccine Adverse Event Reporting System (VAERS). While a VAERS entry does ​not ⁤automatically confirm a vaccine-related cause, it typically initiates further medical investigation.

Agency documents reviewed by Reuters indicate the FDA is‍ currently‍ investigating the ​deaths of at least 10 children following COVID-19 vaccination. Cases under scrutiny include instances of myocarditis, or inflammation of the heart muscle. However, a definitive ‍causal link between the vaccinations and these deaths has not yet been established, ⁣and the specific vaccines administered in these cases remain undisclosed by the FDA‍ and in cited⁢ media reports.

Experts note ​that previous evaluations conducted ⁢by the Centers for Disease Control and Prevention (CDC) did not reveal a clear connection between the vaccines and child​ deaths. Though, the⁢ FDA’s recent statements suggest an‍ internal‌ shift within the agency towards stricter security requirements and increased data transparency, prompted by internal evaluations ⁤suggesting a potential connection.

The FDA ⁣plans to ‍introduce the new regulations ‍in the coming weeks,⁤ potentially requiring larger studies, extended observation periods, ⁢and more rigorous assessment of​ potential side effects. The agency has declined to provide detailed comments on⁣ the ongoing investigations.

This is not the first time the FDA‍ has ‌examined potential links ⁢between COVID-19 vaccines and adverse ‍events in children. The Berliner Zeitung previously reported ⁣in September that the FDA ​was investigating 25 deaths in children following vaccination.⁣ Then-FDA ⁣Commissioner Marty makary acknowledged the reports but stressed the causes remained unclear. The report stemming from that investigation has not yet been published. Vinay Prasad’s current statements indicate a reassessment is⁢ underway within the FDA.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.